Study of Talimogene Laherparepvec With Atezolizumab for Triple Negative Breast Cancer and Colorectal Cancer With Liver Metastases
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Metastatic Triple Negative Breast Cancer|Metastatic Colorectal Cancer
Interventions: BIOLOGICAL: Talimogene Laherparepvec|BIOLOGICAL: Atezolizumab
Sponsor: Amgen
Collaborators: Roche-Genentech